| |
|
|
| Name: |
TCG Crossover Management LLC |
| City: |
PALO ALTO |
| State: |
CA |
| Zip: |
94301 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
38 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
CGON |
CG Oncology, Inc |
1 |
New |
$32.71 |
$156,732,000 |
3,570,206 |
12.39% |
156,732,000 |
3,570,206 |
5.409 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
2 |
- |
$31.22 |
$75,238,000 |
2,650,150 |
5.95% |
53,291,000 |
1,000,000 |
3.267 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
3 |
New |
$9.02 |
$74,301,000 |
5,278,928 |
5.87% |
74,301,000 |
5,278,928 |
9.656 |
N/A |
|
|
SLN |
Silence Therapeutics Adr Re... |
4 |
- |
$0.00 |
$71,180,000 |
3,295,350 |
5.63% |
34,618,000 |
1,190,475 |
11.055 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
5 |
- |
$37.06 |
$68,508,000 |
1,598,421 |
5.42% |
-17,479,000 |
-511,163 |
3.446 |
N/A |
|
|
AVTE |
Aerovate Therapeutics, Inc. |
6 |
- |
$0.00 |
$65,092,000 |
2,201,274 |
5.15% |
15,277,000 |
0 |
7.955 |
N/A |
|
|
INBX |
Inhibrx, Inc. |
7 |
- |
$0.00 |
$61,194,000 |
1,750,387 |
4.84% |
-5,321,000 |
0 |
3.694 |
N/A |
|
|
KROS |
Keros Therapeutics, Inc. |
8 |
New |
$0.00 |
$58,213,000 |
879,344 |
4.6% |
58,213,000 |
879,344 |
2.588 |
N/A |
|
|
GERN |
Geron Corporation |
9 |
- |
$3.48 |
$57,392,000 |
17,391,639 |
4.54% |
8,069,000 |
-5,984,200 |
3.203 |
Drug Manufacturers - ... |
|
|
SVRA |
Savara Inc |
10 |
- |
$4.08 |
$49,800,000 |
10,000,000 |
3.94% |
2,800,000 |
0 |
7.389 |
Biotechnology |
|
|
OCUL |
Ocular Therapeutix, Inc |
11 |
New |
$0.00 |
$48,404,000 |
5,319,148 |
3.83% |
48,404,000 |
5,319,148 |
4.826 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
12 |
- |
$8.22 |
$41,761,000 |
6,214,375 |
3.3% |
8,650,000 |
583,333 |
6.56 |
N/A |
|
|
EWTX |
Edgewise Therapeutics, Inc. |
13 |
New |
$0.00 |
$41,455,000 |
2,272,728 |
3.28% |
41,455,000 |
2,272,728 |
2.463 |
N/A |
|
|
MLYS |
Mineralys Therapeutics, Inc. |
14 |
New |
$0.00 |
$41,121,000 |
3,185,185 |
3.25% |
41,121,000 |
3,185,185 |
7.795 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
15 |
- |
$229.58 |
$39,865,000 |
149,283 |
3.15% |
-1,764,000 |
-30,634 |
0.756 |
Diagnostic Substances |
|
|
TRML |
Tourmaline Bio |
16 |
- |
$0.00 |
$33,837,000 |
1,477,593 |
2.68% |
7,450,000 |
469,691 |
3.577 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
17 |
- |
$0.00 |
$32,621,000 |
1,989,103 |
2.58% |
5,072,000 |
0 |
4.82 |
N/A |
|
|
CMPS |
Compass Pathways Plc |
18 |
- |
$0.00 |
$32,099,000 |
3,858,000 |
2.54% |
-1,659,000 |
0 |
11.083 |
N/A |
|
|
KURA |
Kura Oncology Inc |
19 |
- |
$21.17 |
$30,366,000 |
1,423,642 |
2.4% |
9,894,000 |
0 |
1.7 |
N/A |
|
|
TARS |
Tarsus Pharmaceuticals, Inc. |
20 |
- |
$0.00 |
$28,856,000 |
793,829 |
2.28% |
5,713,000 |
-349,028 |
2.398 |
N/A |
|
|
ADVM |
Adverum Biotechnologies, Inc |
21 |
New |
$7.60 |
$28,398,000 |
2,008,340 |
2.25% |
28,398,000 |
2,008,340 |
1.988 |
N/A |
|
|
SLNO |
Soleno Therapeutics Inc |
22 |
New |
$0.16 |
$23,540,000 |
550,000 |
1.86% |
23,540,000 |
550,000 |
0.691 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
23 |
- |
$0.00 |
$23,061,000 |
2,040,816 |
1.82% |
6,816,000 |
0 |
2.335 |
N/A |
|
|
ABVX |
Abivax S.A |
24 |
- |
$13.86 |
$15,730,000 |
1,100,000 |
1.24% |
3,960,000 |
0 |
1.774 |
N/A |
|
|
VTGN |
Vistagen Therapeutics Inc |
25 |
- |
$4.08 |
$14,132,000 |
2,676,580 |
1.12% |
374,000 |
0 |
9.902 |
Biotechnology |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
26 |
- |
$11.30 |
$13,797,000 |
1,163,356 |
1.09% |
-27,798,000 |
-2,232,139 |
3.06 |
N/A |
|
|
CCCC |
C4 Therapeutics, Inc. |
27 |
- |
$0.00 |
$10,430,000 |
1,276,574 |
0.82% |
3,217,000 |
0 |
2.59 |
N/A |
|
|
TRDA |
Entrada Therapeutics, Inc. |
28 |
- |
$0.00 |
$8,289,000 |
584,955 |
0.66% |
-538,000 |
0 |
1.874 |
N/A |
|
|
ANTX |
An2 Therapeutics Ord Shs |
29 |
- |
$2.02 |
$5,054,000 |
1,555,118 |
0.4% |
-49,823,000 |
-1,123,091 |
5.229 |
N/A |
|
|
KOD |
Kodiak Sciences Inc. |
30 |
- |
$3.07 |
$4,734,000 |
899,999 |
0.37% |
3,919,000 |
632,058 |
2.009 |
N/A |
|
|
VTYX |
Ventyx Biosciences, Inc. |
31 |
- |
$4.37 |
$4,486,000 |
815,724 |
0.35% |
2,471,000 |
0 |
1.622 |
N/A |
|
|
NKTR |
Nektar Therapeutics |
32 |
New |
$1.64 |
$3,737,000 |
4,000,000 |
0.3% |
3,737,000 |
4,000,000 |
2.23 |
Drug Delivery |
|
|
CABA |
Cabaletta Bio, Inc. |
33 |
- |
$0.00 |
$1,481,000 |
86,795 |
0.12% |
-9,569,000 |
-400,000 |
0.169 |
N/A |
|
|
GRCL |
Gracell Biotechnologies Adr... |
35 |
Closed |
$0.00 |
$0 |
0 |
0% |
-45,328,000 |
-4,514,786 |
0 |
N/A |
|
|
ICVX |
Icosavax, Inc. |
34 |
Closed |
$0.00 |
$0 |
0 |
0% |
-58,370,000 |
-3,703,704 |
0 |
N/A |
|
|
NRIX |
Nurix Therapeutics, Inc. |
38 |
Closed |
$0.00 |
$0 |
0 |
0% |
-7,406,000 |
-717,654 |
0 |
N/A |
|
|
RYZB |
Rayzebio, Inc. |
36 |
Closed |
$62.49 |
$0 |
0 |
0% |
-54,082,000 |
-869,908 |
0 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
37 |
Closed |
$0.00 |
$0 |
0 |
0% |
-5,156,000 |
-2,912,861 |
0 |
N/A |
|
